Printed From:

Proven safety profile shown in clinical trials

Incidence of hypoglycemia in adult patients with t2dm treated with soliqua 100/33 in clinical trials

*Severe symptomatic hypoglycemia defined as an event requiring assistance of another person to actively administer carbohydrate, glucagon, or other resuscitative actions.

Documented symptomatic hypoglycemia defined as an event with typical symptoms of hypoglycemia accompanied by a self-monitored plasma glucose value equal to or less than 70 mg/dL.

Treatment-emergent adverse events with (frequency ≥5%) in 2 pooled clinical trials

Gastrointestinal adverse reactions occur more frequently at the beginning of therapy.